¥È¥Ã¥×
|
²ñ¼Ò³µÍ×
|
¶È̳ÈÏ°Ï
|
ÆÈÆäÊËÝÌõÉô
|
ÉʼÁÊݾÚ
|
À®¸ùÎã
|
ºÎÍѾðÊó
|
¤ªÌ䤤¹ç¤ï¤»
¶È̳ÈÏ°Ï
 
´ðÁðå³Ø¤ÈÎ×¾² ¾Ü¤·¤¯

À¸Íý³Ø¡¢ÉÂÍý³Ø¡¢À¸Êª²½³Ø¡¢Ê¬»ÒÀ¸Êª³Ø¡¢¥Ð¥¤¥ª°å³Ø¹©Äø¡¢½Û´Ä´ïÆâ²Ê¡¢¸ÆµÛ´ïÆâ²Ê¡¢Ç¾³°²Ê¡¢¿À·Ð³°²Ê...

 
Ìô³Ø»ñÎÁ ¾Ü¤·¤¯

ÌôÍý³Ø¡¢ÆÇÍý³Ø¡¢ÌôÉʲ½³Ø¡¢ÌôÉÊʬÀϳء¢ÌôºÞ³Ø¡¢À½ºÞ½èÊý¤ª¤è¤Óµ»½Ñ¡¢¸¶ÎÁ¡¦ÊäºÞ¤ÎͳÍ褪¤è¤ÓÉʼÁ´ð...

 
°åÎÅ´ï³£¤ª¤è¤ÓÀ½ÉÊ ¾Ü¤·¤¯

IEC¡Ê¹ñºÝÅŵ¤É¸½à²ñµÄ¡ËÊó¹ð¡¢¥ì¥ó¥È¥²¥óµ¡´ï¡¢Ä¶²»Çȵ¡´ï¡¢MRI¡¢CT¡¢¸ÆµÛµ¡¡¢·ì±Õ¾ô²½Íѵ¡...

 
¹ñºÝ²ñµÄƱ»þÄÌÌõ ¾Ü¤·¤¯

¹ñºÝ²ñµÄ¡¢¸¦µæƤÏÀ²ñ¡¢Ç¯²ñ²ñµÄ¤Î¸½¾ìÄÌÌõ¡¢Æ±»þÄÌÌõ¡¢±óµ÷Î¥²ñµÄËÝÌõ¡¢±ÇÁü»ñÎÁ¡¢Âç²ñµÄÆüÄøËÝÌõ¡¢...

À®¸ùÎã
SFDA
WHO(World Health
WHO(World Health
Novartis Pharma
Beijing Municipa
Bayer
Healthcare
Chinese Medical
Nycomed Pharma
 
 
·­Òë´Ê»ãÏÂÔØ
»ù´¡Ò½Ñ§´Ê»ã
¡¡¡¤ ²¡ÀíÉúÀíѧ´Ê»ã ¡¡¡¤ ½âÆÊѧ´Ê»ã ¡¡¡¤ ϸ°ûÉúÎïѧ´Ê»ã
¡¡¡¤ ҽѧ΢ÉúÎïѧ´Ê»ã ¡¡¡¤ ҽѧÒÅ´«Ñ§´Ê»ã
²¡ÀíÉúÀíѧ´Ê»ã
English
ÖÐÎÄ
English
ÖÐÎÄ
adaptive hypertrophy
ÊÊÓ¦ÐÔ·Ê´ó
isotonic dehydration
µÈÉøÐÔȱˮ
aerosis
ÆøÌå²úÉú
isotonic hypoxemia
µÈÕÅÐÔµÍÑõѪ֢
afterload
ºó¸ººÉ
ketoacidosis
֢ͪËáÖж¾
afuction
¹¦ÄÜɥʧ
ischemic anoxia
ȱѪÐÔȱÑõ
anatomic shunt
½âÆʶÌ·
lactic acidosis
ÈéËáËáÖж¾
anoxia
ȱÑõ
low output heart failure
µÍÊä³öÁ¿ÐÔÐÄÁ¦Ë¥½ß
anuria
ÎÞÄò
metabolic acidosis
´úлÐÔËáÖж¾
autoinfusion
×ÔÉíÊäÒº
metabolic alkalosis
´úлÐÔ¼îÖж¾
autotransfusion
×ÔÉíÊäѪ
microangiopathic hemolytic anemia
΢Ѫ¹Ü²¡ÐÔÈÜѪÐÔƶѪ
azotemia
µªÖÊѪ֢
myocardial contractility
Ðļ¡ÊÕËõÐÔ
blood urea nitrogen (BUN)
ѪÄòËصª
myocardial failure
Ðļ¡Ë¥½ß
brain death
ÄÔËÀÍö
myocardial hypertrophy
Ðļ¡·Ê´ó
cardiac asthma
ÐÄÔ´ÐÔÏø´­
nitremia
µªÖÊѪ֢
cardiac insufficiency
ÐŦÄܲ»È«
nocturia
Ò¹Äò
cellular edema
ϸ°ûË®Ö×
nonoliguric acute renal failure
·ÇÉÙÄòÐͼ±ÐÔÉö¹¦ÄÜË¥½ß
dead space like ventilation
ËÀÇ»ÑùͨÆø
nuclear jaundice
ºË»Æðã
dehydration
ÍÑË®
obstructive hypoventilation
×èÈûÐÔͨÆø²»×ã
diffusion impairment
ÃÖÉ¢ÕÏ°­
obstructive jaundice
¹£×èÐÔ»Æðã
eccentric hypertrophy
Ô¶ÐÄÐÔ·Ê´ó
occult edema
ÒþÐÔË®Ö×
enterogenous cyanosis
³¦Ô´ÐÔ×Ïç¤
oliguria
ÉÙÄò
exogenous pyrogen
ÍâÔ´ÐÔÖÂÈÈÔ´
orthopnea
Ç¿ÆÈ×øλ¡¢¶Ë×øºôÎü
false neurotransmitter
¼ÙÐÔÉñ¾­½éÖÊ
oxygen capacity
ѪÑõÈÝÁ¿
filtrate passive back flow
Ô­Äò»Ø©
oxygen content
ѪÑõº¬Á¿
frank edema
ÏÔÐÔË®Ö×
paroxysmal nocturnal dyspnea
Ò¹¼äÕó·¢ÐÔºôÎüÀ§ÄÑ
functional dead space
¹¦ÄÜÐÔËÀÇ»
pathological process
²¡Àí¹ý³Ì
heart failure
ÐÄÁ¦Ë¥½ß
pathophysiology
²¡ÀíÉúÀíѧ
hemic hypoxia
ѪҺÐÔȱÑõ
pathophysiology
²¡ÀíÉúÀíѧ
hepatic encephalopathy
¸ÎÐÔÄÔ²¡
postrenal acute renal failure
ºóÐÔ¼±ÐÔÉö¹¦ÄÜË¥½ß
hepatic insufficiency
¸Î¹¦Äܲ»È«
preload
Ç°¸ººÉ
hepatocellular jaundice
¸Îϸ°ûÐÔ»Æðã
prerenal acute renal failure
ÉöÇ°ÐÔ¼±ÐÔÉö¹¦ÄÜË¥½ß
high output heart failure
¸ßÊä³öÁ¿ÐÔÐÄÁ¦Ë¥½ß
pressure overload
ѹÁ¦¸ººÉ¹ý¶È
histogenous hypoxia
×éÖ¯ÐÔȱÑõ
pulmonary encephalopathy
·ÎÐÔÄÔ²¡
histotoxic hypoxia
×éÖ¯Öж¾ÐÔȱÑõ
pump failure
±ÃË¥½ß
hydrops
»ýË®,»ýÒº
recessive edema
ÒþÐÔË®Ö×
hyperbilirubinemia
¸ßµ¨ºìËØѪ֢
renal anemia
ÉöÐÔƶѪ
hyperdynamic shock
¸ß¶¯Á¦ÐÍÐÝ¿Ë
renal insufficiency
Éö¹¦Äܲ»È«
hyperkalemia
¸ß¼ØѪ֢
renal osteodystrophy
ÉöÐÔ¹ÇÓªÑø²»Á¼
hypertonic dehydration
¸ßÉøÐÔÍÑË®
respiratory acidosis
ºôÎüÐÔËáÖж¾
hypodynamic shock
µÍÖ§Á¦ÐÍÐÝ¿Ë
respiratory alkalosis
ºôÎüÐÔ¼îÖж¾
hypokalemia
µÍ¼ØѪ֢
respiratory failure
ºôÎüË¥½ß
hyposthenuria
µÍÉøÄò
respiratory hypoxia
ºôÎüÐÔȱÑõ
hypotonic dehydration
µÍÉøÐÔȱˮ
respiratory insufficiency
ºôÎü¹¦Äܲ»È«
hypotonic hypoxemia
µÍÕÅÐÔµÍÑõѪ֢
restrictive hypoventilation
ÏÞÖÆÐÔͨÆø²»×ã
hypovolemic shock
µÍѪÈÝÁ¿ÐÔÐÝ¿Ë
shock
ÐÝ¿Ë
hypoxic hypoxia
·¦ÑõÐÔȱÑõ
traumatic apnea
´´ÉËÐÔºôÎüÔÝÍ£
incomplete recovery
²»ÍêÈ«»Ö¸´½¡¿µ
ulcerative proctitis
À£ÑñÐÔÖ±³¦Ñ×
infectious shock
¸ÐȾÐÔÐÝ¿Ë
uterine insufficiency
×Ó¹¬¹¦Äܲ»È«
 
©

2004-2019Ë̵þ°ÉÎÓ°åÌôËÝÌõ¥»¥ó¥¿¡¼